Your browser doesn't support javascript.
loading
Gpr75-deficient mice are protected from high-fat diet-induced obesity.
Hossain, Sakib; Gilani, Ankit; Pascale, Jonathan; Villegas, Elizabeth; Diegisser, Danielle; Agostinucci, Kevin; Kulaprathazhe, Melissa-Maria; Dirice, Ercument; Garcia, Victor; Schwartzman, Michal Laniado.
Affiliation
  • Hossain S; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Gilani A; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Pascale J; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Villegas E; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Diegisser D; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Agostinucci K; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Kulaprathazhe MM; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Dirice E; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Garcia V; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
  • Schwartzman ML; Department of Pharmacology, New York Medical College School of Medicine, Valhalla, New York, USA.
Obesity (Silver Spring) ; 31(4): 1024-1037, 2023 04.
Article de En | MEDLINE | ID: mdl-36854900
ABSTRACT

OBJECTIVE:

G-protein coupled receptor 75 (GPR75) has been identified as the high-affinity receptor of 20-hydroxyeicosatetraenoic acid (20-HETE), a vasoactive and proinflammatory lipid, and mice overproducing 20-HETE have been shown to develop insulin resistance when fed a high-fat diet (HFD), which was prevented by a 20-HETE receptor blocker. Simultaneously, a large-scale exome sequencing of 640,000 subjects identified an association between loss-of-function GPR75 variants and protection against obesity.

METHODS:

Wild-type (WT) and Gpr75-deficient mice were placed on HFD for 14 weeks, and their obesity phenotype was examined.

RESULTS:

Male and female Gpr75 null (knockout [KO]) and heterozygous mice gained less weight than WT mice when placed on HFD. KO mice maintained the same level of energy expenditure during HFD feeding, whereas WT mice showed a significant reduction in energy expenditure. Diet-driven adiposity and adipocyte hypertrophy were greatly lessened in Gpr75-deficient mice. HFD-fed KO mice did not develop insulin resistance. Adipose tissue from Gpr75-deficient mice had increased expression of thermogenic genes and decreased levels of inflammatory markers. Moreover, insulin signaling, which was impaired in HFD-fed WT mice, was unchanged in KO mice.

CONCLUSIONS:

These findings suggest that GPR75 is an important player in the control of metabolism and glucose homeostasis and a likely novel therapeutic target to combat obesity-driven metabolic disorders.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Alimentation riche en graisse Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Obesity (Silver Spring) Sujet du journal: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Alimentation riche en graisse Type d'étude: Prognostic_studies Limites: Animals Langue: En Journal: Obesity (Silver Spring) Sujet du journal: CIENCIAS DA NUTRICAO / FISIOLOGIA / METABOLISMO Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique